Started By
Message

re: Would you save a dying kid?

Posted on 3/24/14 at 1:11 pm to
Posted by Teddy Ruxpin
Member since Oct 2006
39750 posts
Posted on 3/24/14 at 1:11 pm to
Ya, bad situation.

I do find it odd they didn't give it for free at the onset since it is "experimental" and would give them great data I would think.

But I don't know the first thing that goes into those types of decisions.
This post was edited on 3/24/14 at 1:12 pm
Posted by Volvagia
Fort Worth
Member since Mar 2006
52065 posts
Posted on 3/24/14 at 1:15 pm to
quote:

would give them great data I would think.


No way for us to know.

But it could just as likely be detrimental.
Posted by Darth_Vader
A galaxy far, far away
Member since Dec 2011
65999 posts
Posted on 3/24/14 at 1:17 pm to
quote:

Would you save a dying kid?


Who wouldn't?

quote:

I do find it odd they didn't give it for free at the onset since it is "experimental" and would give them great data I would think.

But I don't know the first thing that goes into those types of decisions.



Good point. There's a lot we don't know about why they were reluctant t let this kid take this medicine.
Posted by PuntBamaPunt
Member since Nov 2010
10070 posts
Posted on 3/24/14 at 1:38 pm to
quote:

I do find it odd they didn't give it for free at the onset since it is "experimental" and would give them great data I would think.

But I don't know the first thing that goes into those types of decisions.


the current trial is for adults. they got the FDA to immediately approve a new clinical trial for kids too (20 patients) so now they can use the data.
Posted by cleeveclever
Baton Rouge
Member since Aug 2008
2046 posts
Posted on 3/24/14 at 1:51 pm to
quote:

Ya, bad situation. I do find it odd they didn't give it for free at the onset since it is "experimental" and would give them great data I would think. But I don't know the first thing that goes into those types of decisions.



These clinical trials are meticulously managed to collect a range of data for the FDA. The problem is that this kids is pretty far gone and his odds are quite low even with the medicine.

Even with "compassionate use", the FDA makes no distinction with the data. If this kid, who is outside of the clinical control of the company, dies -- even if it is of no fault of the drug -- his death has to be included in the data.

The FDA takes death very seriously (as they should), so it can possibly delay the release of the drug for years -- keeping it out of the hands of large numbers of people who need it. Thousands who could've been treated could theoretically die during the delay -- a delay that was caused because a dying child was administered the medicine due to outside pressure.

It's a tough issue. Even compassionate use typically has strict guidelines. The drug companies want to make their money and the sick want their medicine, but the FDA controls the availability -- and they are very rigid.
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram